Nicovations

Nicovations is a specialized subsidiary of British American Tobacco (BAT) focused on the development and regulatory approval of medicinal nicotine delivery products. The company gained prominence for its role in the commercialization of Voke, a breath-activated nicotine inhaler that was the first of its kind to receive a medicinal license from the UK's Medicines and Healthcare products Regulatory Agency (MHRA). Unlike electronic cigarettes, the technology associated with Nicovations does not involve heat or electronics, instead using a pressurized canister to deliver nicotine. While the commercial rights to Voke were eventually returned to its original developer, Nicovations continues to represent BAT's interests in the pharmaceutical-grade nicotine replacement therapy market. The company's work is a key component of the broader corporate strategy to provide reduced-risk alternatives to traditional tobacco. Nicovations operates at the intersection of medical device engineering and pharmaceutical science.